Trials / Completed
CompletedNCT00215436
A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate in the Treatment of Patients With COPD
A 12-week Double-Blind, Parallel-Group, Placebo- and Active- Controlled Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate Inhalation Solution 20 Mcg in the Treatment of Patients With Chronic Obstructive Pulmonary Disease
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 345 (planned)
- Sponsor
- Dey · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the safety and efficacy of the investigational drug in comparison with a placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Formoterol Fumarate |
Timeline
- Start date
- 2005-03-01
- Primary completion
- 2005-09-01
- Completion
- 2006-09-01
- First posted
- 2005-09-22
- Last updated
- 2010-11-10
Locations
44 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00215436. Inclusion in this directory is not an endorsement.